Ads
related to: new biomarker predictions for cancer- MET Biomarker Testing
Explore MET Biomarker Testing
Methodologies & Detection Methods
- Poor Prognosis In NSCLC
Learn about MET Biomarkers
and Poorer Prognosis in NSCLC
- MET Aberrations In NSCLC
Review the Current & Emerging MET
Biomarkers Prevalent in NSCLC
- MET Biomarker Prevalence
Explore MET Biomarkers
Prevalent in NSCLC
- MET Biomarker Testing
Search results
Results From The WOW.Com Content Network
A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer.
The vast amount of experimental data has enabled the specific microRNA signatures and profiles to be recognised and thus used as potential biomarkers in cancer diagnosis, therapy prediction and prognosis. miR-129 has been identified as a potential candidate for development into a diagnostic biomarker.
In recent years, advances in molecular techniques, genomics, cancer biology and sequencing technology have provided opportunities to discover and validate new biomarkers for prognosis, particularly molecular prognostic markers.
The BRAF Inhibitors market is expected to grow significantly in the coming years. This is due to the increasing number of patients being diagnosed with cancer, rise in biomarker testing rates, the growing usage and awareness of BRAF Inhibitors, and increase in clinical development of next-generation BRAF-targeting therapies.
There are many different types of breast cancer, of which triple-negative breast cancer is one of the hardest to treat. A new cell study has identified two inhibitors that, when used together ...
The mRNA-based disease diagnosis technologies have been applied to medical field widely in recent years, especially on early diagnosis of tumors (such as renal cell carcinoma, [2] hepatocellular carcinoma, [3] [4] breast cancer [5] and prostate cancer [6]). The technology can be applied to various types of samples depending on how easily the ...
Ad
related to: new biomarker predictions for cancer